Stock Fundamentals

Company Information

▼
Company Name
Intra-Cellular Therapies Inc
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
ISIN: US46116X1019
CIK: 0001567514
CUSIP: 46116X101
Currency: USD
Full Time Employees: 860
Phone: 646 440 9333
Website: https://www.intracellulartherapies.com
Fiscal Year End: December
IPO Date: Jan 07, 2014
Description:

Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company that develops and commercializes therapeutics and small molecule drugs for central nervous system (CNS), neuropsychiatric, and neurological disorders. The company offers CAPLYTA for the treatment of schizophrenia and bipolar depression in adults. It distributes its products through third-party wholesale drug distributors. The company was founded in 2002 and is based in Bedminster, New Jersey. As of April 2, 2025, Intra-Cellular Therapies, Inc. operates as a subsidiary of Johnson & Johnson Innovative Medicine.

Address:

135 Route 202/206, Bedminster, NJ, United States, 07921

Directors & Officers

▼
Name Title Year Born
Dr. Sharon Mates Ph.D. Co-Founder, Chairman & CEO 1953
Mr. Michael I. Halstead J.D. President 1973
Mr. Sanjeev Narula Executive VP, CFO & Treasurer 1962
Dr. Suresh K. Durgam M.D. Executive VP & Chief Medical Officer 1970
Mr. Mark Neumann EVP & Chief Commercial Officer 1964
Dr. Robert E. Davis Ph.D. Senior VP & Chief Scientific Officer 1951
Mr. Juan Fernando Sanchez M.D. Vice President of Corporate Communications & Investor Relations 1971
Ms. Karen Patruno Sheehy Esq. Senior VP & Chief Compliance Officer 1962
John P. Condon Senior VP, General Counsel & Secretary NA
Dr. Michael Olchaskey Pharm.D. Senior VP & Head of Regulatory Affairs NA

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 9.52M Mar 31, 2025 8.95% $0.02 -2.07%
BlackRock Inc 8.75M Mar 31, 2025 8.23% $0.02 43.23%
Pentwater Capital Management LP 5.19M Mar 31, 2025 4.88% $5.75 0.00%
Davidson Kempner Capital Management LP 3.49M Mar 31, 2025 3.28% $9.46 0.00%
NORGES BANK 3.21M Dec 31, 2024 3.02% $0.04 65.30%
UBS O'Connor LLC 3.09M Mar 31, 2025 2.91% $33.23 15,139.27%
Amvescap Plc. 3.08M Dec 31, 2024 2.89% $0.05 2.93%
Farallon Capital Management, L.L.C. 3.06M Mar 31, 2025 2.87% $2.25 0.00%
FMR Inc 2.66M Mar 31, 2025 2.50% $0.02 -75.96%
Balyasny Asset Management LLC 2.26M Mar 31, 2025 2.12% $0.49 1,516.72%
Deep Track Capital, LP 2.00M Mar 31, 2025 1.88% $8.54 0.00%
Geode Capital Management, LLC 1.83M Mar 31, 2025 1.72% $0.02 6.71%
Bank of America Corp 1.82M Mar 31, 2025 1.71% $0.02 398.20%
State Street Corp 1.78M Mar 31, 2025 1.68% $0.01 -4.99%
Weiss Asset Management LP 1.64M Mar 31, 2025 1.54% $4.36 0.00%
Glazer Capital, LLC 1.58M Mar 31, 2025 1.49% $9.64 0.00%
Goldman Sachs Group Inc 1.47M Mar 31, 2025 1.39% $0.03 291.52%
Morgan Stanley - Brokerage Accounts 1.40M Mar 31, 2025 1.32% $0.01 57.26%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 1.09M Mar 31, 2025 1.03% $0.53 0.00%
Test Hedge Fund Mgmt 1.06M Mar 31, 2025 0.99% $8.73 0.00%

Shares Statistics

▼
Shares Outstanding: 106.52M
Shares Float: 104.82M
% Insiders: 248.30%
% Institutions: 9,645.00%
Short % Float: 2.54%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Group Inc 9.52M 8.95% ▼ 2.07% Mar 31, 2025
2 BlackRock Inc 8.75M 8.23% ▲ 43.23% Mar 31, 2025
3 Pentwater Capital Management LP 5.19M 4.88% ▲ 0.00% Mar 31, 2025
4 Davidson Kempner Capital Management LP 3.49M 3.28% ▲ 0.00% Mar 31, 2025
5 NORGES BANK 3.21M 3.02% ▲ 65.30% Dec 31, 2024
6 UBS O'Connor LLC 3.09M 2.91% ▲ 15,139.27% Mar 31, 2025
7 Amvescap Plc. 3.08M 2.89% ▲ 2.93% Dec 31, 2024
8 Farallon Capital Management, L.L.C. 3.06M 2.87% ▲ 0.00% Mar 31, 2025
9 FMR Inc 2.66M 2.50% ▼ 75.96% Mar 31, 2025
10 Balyasny Asset Management LLC 2.26M 2.12% ▲ 1,516.72% Mar 31, 2025

Valuation Metrics

▼
Enterprise Value: $13.06B
Trailing P/E: 0.00
Forward P/E: 158.73

Financial Highlights

▼
Market Cap: $14.05B
EBITDA: $-116.21M
PEG Ratio: $0.00
Book Value: $10.81
Earnings/Share: $-0.73
Profit Margin: -10.97%
Operating Margin: -14.66%
ROA (TTM): -6.96%
ROE (TTM): -8.58%
Revenue (TTM): $680.85M
Revenue/Share (TTM): $6.60
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 50.80%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 6.36x 0.00x 0.16x N/A -0.04x
2023-12-31 5.41x 0.01x 0.19x N/A -0.02x
2022-12-31 8.87x 0.01x 0.13x -35.74x -0.03x
2021-12-31 8.76x 0.02x 0.15x -135.95x -0.02x
2020-12-31 18.75x 0.01x 0.08x -48.54x -0.02x
2019-12-31 6.36x 0.02x 0.22x -22.75x -0.02x
2018-12-31 9.79x 0.00x 0.11x N/A 0.00x
2017-12-31 33.02x 0.00x 0.04x N/A 0.00x
2016-12-31 36.86x 0.00x 0.03x -3,215.22x 0.00x
2015-12-31 77.15x 0.00x 0.02x -14.96x 0.00x
2014-12-31 12.41x 0.00x 0.08x -4,380.99x 0.00x
2013-12-31 5.60x 0.00x 0.18x -42.85x 0.00x
2012-12-31 6.91x 0.00x 0.14x -84.77x 0.00x
2011-12-31 0.00x 0.00x 0.24x N/A 0.00x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 03, 2025 Josh Gottheimer N/A Sale N/A $131.87 N/A
Apr 03, 2025 Gilbert Ray Cisneros, Jr. N/A Sale N/A $131.87 N/A
Mar 24, 2025 Gilbert Ray Cisneros, Jr. N/A Sale N/A $131.70 N/A
Mar 17, 2025 Josh Gottheimer N/A Sale N/A $131.45 N/A
Jan 24, 2025 Josh Gottheimer N/A Sale N/A $127.35 N/A
Dec 04, 2024 Sharon Mates N/A Sale 51.00K $85.80 $4.38M
Nov 12, 2024 Michael Halstead N/A Sale 22.87K $89.12 $2.04M
Aug 30, 2024 Sharon Mates N/A Sale 34.40K $72.84 $2.51M
Aug 27, 2024 Sharon Mates N/A Sale 40.51K $73.58 $2.98M
Aug 23, 2024 Sharon Mates N/A Sale 28.68K $74.46 $2.14M
Aug 21, 2024 Sharon Mates N/A Sale 53.01K $75.65 $4.01M
Aug 16, 2024 Mark Neumann N/A Sale 18.71K $75.08 $1.41M
Jun 24, 2024 Rory B Riggs N/A Sale 4.46K $75.57 $337.19K
Jun 21, 2024 Josh Gottheimer N/A Sale N/A $76.58 N/A
Jun 18, 2024 Nostrand Robert L Van N/A Sale 20.00K $75.91 $1.52M

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ITCI.US!